India  

Shocking! Bihar woman gets both Covaxin, Covishield shots in 5 minutes interval - what happened next, know here

DNA Saturday, 19 June 2021
If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said.
0
shares
ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Bihar Bihar State in eastern India

Act against Moitra for her ‘unethical behaviour’: BJP MP

BJP MP Nishikant Dubey on Thursday alleged in Lok Sabha that TMC member Mohua Moitra had used derogatory remarks against him during a parliamentary committee..
IndiaTimes

Dalit children more likely to be stunted, shows study

A data narrative published by Ashoka University’s Centre for Economic Data and Analysis shows that stunting is much more likely among Dalit children in areas..
IndiaTimes

Madhya Pradesh records highest antibodies with 79%, followed by Rajasthan, Bihar: ICMR serosurvey

At least two-thirds of the population surveyed in eleven states were found to have developed coronavirus antibodies
DNA

Covaxin Covaxin Vaccine against COVID-19

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a..
IndiaTimes

Brazil's Anvisa provisionally suspends authorisation for exceptional import of 4 million Covaxin doses

After closing the emergency use authorisation (EUA) and Phase-3 clinical trials requests for Bharat Biotech’s Covaxin, Brazil’s health regulator Anvisa..
IndiaTimes

After suspending Covaxin clinical trials, Brazil closes EUA request

After suspending the clinical trials of Covaxin following the termination of Bharat Biotech's MoU with its Brazilian partner Precisa Medicamentos, Brazil’s..
IndiaTimes

COVID-19 vaccine for children likely by September: AIIMS Chief

In view of a probable third wave of the pandemic, vaccination trials on children have been underway in India with Covaxin and Zydus Cadila's ZyCov-D.
DNA

Oxford–AstraZeneca COVID-19 vaccine Oxford–AstraZeneca COVID-19 vaccine Vaccine against COVID-19

Covishield generates 93% protection, says AFMC study

Covishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta..
IndiaTimes

Covishield reduces fresh infections by 93%, deaths by 98%: AFMS study

A study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the..
IndiaTimes

NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: Govt

The recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the..
IndiaTimes
French Government allows Covishield-jabbed travellers into the country | AstraZeneca | Oneindia News [Video]

French Government allows Covishield-jabbed travellers into the country | AstraZeneca | Oneindia News

From today, France will allow international travellers who have had AstraZeneca’s Indian-manufactured vaccine into the country. Covishield is being accepted all across the world. #Covishield #France #SII

Credit: Oneindia    Duration: 01:39Published

Related news from verified sources

Centre rejects reports of dissent by experts on Covishield doses gap

The 22nd meeting of COVID-19 Working Group of NTAGI was held on May 10. There, a proposal for a change in dose interval for Covishield, used under the National...
Zee News Also reported by •IndiaTimesMid-DayDNA

'Matter of time': SII's Poonawalla confident of getting EU green pass for Covishield

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter...
IndiaTimes Also reported by •Mid-Day

Covishield single shot is 61% effective against delta strain: Covid Panel Chief

Amid the ongoing debate over the gap between two doses of the Covishield vaccine, COVID Working Group chief Dr NK Arora revealed that, as per the research, Serum...
Zee News Also reported by •DNA